Ruoshi Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ruoshi Shi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ke Ding
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication - Lele Zhang
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication - Qing-Tao Meng
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication - Rong Chen
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication - Yiguo Zhang
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication - Yixin Jing
Department of Anesthesiology Renmin Hospital of Wuhan University Wuhan China
1 shared publication
Latest Publications
- 22 January 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (2) , e71495
β ‐Hydroxybutyric Acid Inhibits Mitochondrial Biogenesis via the HDAC2 / SIRT7 Signaling Pathway After Intestinal Ischemia–Reperfusion
β ‐hydroxybutyric acid (BHB), a key ketone body with energy substrate and epigenetic regulatory roles, has contradictory effects in pathological contexts. Intestinal ischemia–reperfusion (IIR) is a life threatening perioperative complication characterized by metabolic disorders and mitochondrial dysfunction, yet BHB's role in IIR remains unclear. Using C57BL/6 mouse IIR models and Caco2 cell hypoxia‐reoxygenation (HR) models, we identified a pathogenic mechanism: IIR induced nearly 10‐fold elevation of intestinal BHB, while ketolytic enzymes 3‐hydroxybutyrate dehydrogenase 1 (BDH1) and 3‐oxoacid CoA‐transferase 1 (OXCT1) were significantly downregulated, blocking BHB's metabolic pathway. Exogenous BHB administration failed to protect the intestine; instead, it selectively inhibited expression of histone deacetylase 2 (HDAC2) (by 30%) and disrupted its nuclear binding to the Sirt7 promoter, promoting Sirt7 gene transcriptional activation (mRNA upregulated by 2‐fold). This cascade exacerbated oxidative stress (reactive oxygen species increased by 2.7‐fold), reduced adenosine triphosphate levels (by 20%), impaired mitochondrial biogenesis (decreased mitochondrial DNA copy number and mitochondrial transcription factor A (TFAM)/mitochondrial ribosomal proteins (MRPs) expression), and aggravated intestinal barrier dysfunction (Claudin‐1 reduced and D‐lactate elevated). Notably, HDAC2 overexpression or SIRT7 knockdown reversed these impairments. Our findings uncover a previously unrecognized role of BHB in exacerbating IIR injury via the HDAC2/SIRT7 pathway, providing new insights for protecting pathological intestinal tissues at ischemic risk and targeting mitochondrial biogenesis.
- 22 January 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (2) , e71495
β ‐Hydroxybutyric Acid Inhibits Mitochondrial Biogenesis via the HDAC2 / SIRT7 Signaling Pathway After Intestinal Ischemia–Reperfusion
β ‐hydroxybutyric acid (BHB), a key ketone body with energy substrate and epigenetic regulatory roles, has contradictory effects in pathological contexts. Intestinal ischemia–reperfusion (IIR) is a life threatening perioperative complication characterized by metabolic disorders and mitochondrial dysfunction, yet BHB's role in IIR remains unclear. Using C57BL/6 mouse IIR models and Caco2 cell hypoxia‐reoxygenation (HR) models, we identified a pathogenic mechanism: IIR induced nearly 10‐fold elevation of intestinal BHB, while ketolytic enzymes 3‐hydroxybutyrate dehydrogenase 1 (BDH1) and 3‐oxoacid CoA‐transferase 1 (OXCT1) were significantly downregulated, blocking BHB's metabolic pathway. Exogenous BHB administration failed to protect the intestine; instead, it selectively inhibited expression of histone deacetylase 2 (HDAC2) (by 30%) and disrupted its nuclear binding to the Sirt7 promoter, promoting Sirt7 gene transcriptional activation (mRNA upregulated by 2‐fold). This cascade exacerbated oxidative stress (reactive oxygen species increased by 2.7‐fold), reduced adenosine triphosphate levels (by 20%), impaired mitochondrial biogenesis (decreased mitochondrial DNA copy number and mitochondrial transcription factor A (TFAM)/mitochondrial ribosomal proteins (MRPs) expression), and aggravated intestinal barrier dysfunction (Claudin‐1 reduced and D‐lactate elevated). Notably, HDAC2 overexpression or SIRT7 knockdown reversed these impairments. Our findings uncover a previously unrecognized role of BHB in exacerbating IIR injury via the HDAC2/SIRT7 pathway, providing new insights for protecting pathological intestinal tissues at ischemic risk and targeting mitochondrial biogenesis.